SK
Samiullah Khan
About Samiullah Khan
Data last updated:
Samiullah Khan is a Managing Director at Novorem Pharmaceuticals Private Limited (since 2012) and Director at Novorem Pharmacy (Opc) Private Limited (since 2026). The companies operate in Trading. The largest current company by reported revenue is Novorem Pharmaceuticals Private Limited at ₹2.53 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novorem Pharmaceuticals Private Limited U51397DL2012PTC246789 | Managing Director | 28 Dec 2012 | 2012 | ₹2.53 Cr (FY 2025) | Active |
| Novorem Pharmacy (Opc) Private Limited U47721UW2026OPC254654 | Director | 19 Jun 2026 | 2026 | Active |
Board colleagues of Samiullah Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Fatima | 08238552 | Novorem Pharmaceuticals Private Limited | Whole-Time Director |
| Huma Khan | 11767788 | Novorem Pharmacy (Opc) Private Limited | Nominee |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samiullah Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samiullah Khan
Samiullah Khan currently holds 2 directorships: Novorem Pharmaceuticals Private Limited (Managing Director, since 28 Dec 2012, revenue ₹2.53 Cr (FY 2025)); Novorem Pharmacy (Opc) Private Limited (Director, since 19 Jun 2026).
Samiullah Khan was first appointed on 28 Dec 2012 as Managing Director at Novorem Pharmaceuticals Private Limited. The most recent appointment on record is 19 Jun 2026 at Novorem Pharmacy (Opc) Private Limited.